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Aim:  Ridge preservation is a common procedure performed in Periodontics to prevent 
ridge resorption following tooth extraction.  The aim of this present investigation is to compare in 
vivo the use of bioengineered Polycaprolactone (Polydopamine Coated and Uncoated) scaffolds 
against a commonly used xenograft, Bio-Ossâ, and Control (no material) in ridge preservation 
procedures following first molar extraction in the rat model.    
Materials and Methods:  33 male Sprague Dawley rats were used in the study.  The 
maxillary right and left first molars were extracted and a standardized defect was created in the 
extraction socket using a slow speed handpiece and a #703 fissure bur.  The rats were equally 
divided and randomly selected to receive one of four ridge preservation materials: Control (no 
material), Bio-Ossâ, Polycaprolactone (Polydopamine Coated) scaffold, or Polycaprolactone 
(Uncoated) scaffold.  All extraction sites were covered by a resorbable collagen membrane.  Rats 
were randomly allocated to either be in the four week or eight week experimental groups.  The rats 
were sacrificed, and the maxillae were dissected and hemisected into right and left halves.  The 
tissues were processed and analyzed.     
Results:  In comparing radiographs, at 4 weeks, the difference in average bone height at 
extraction sockets was not statistically significant (p > 0.05) for any of the materials tested.  At 8 
weeks, the difference in average bone height at extraction sockets was statistically significant (p < 
0.05) between Control and Bio-Ossâ, Polycaprolactone (Uncoated), and Polycaprolactone 
(Polydopamine Coated).  Micro-CT analysis revealed greater bone fill in the extraction sockets in 
the 8-week samples compared with the 4-week samples, and all samples showed a loss of residual 
bone height.  Paraffin sections demonstrated that Control, Bio-Ossâ, and Polycaprolactone 





by endochondral ossification.  New mineralized tissue formation was seen inside the fibrous 
connective tissue in all 8-week ground section samples.       
Conclusion:  Both Polycaprolactone (Polydopamine Coated and Uncoated) scaffolds 
performed comparably to Bio-Ossâ as a ridge preservation material over the Control (no material).  
Though new bone formation was seen with all treatment modalities, there was an improvement 
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1. INTRODUCTION AND LITERATURE REVIEW 
 
Background and Introduction 
 
Extraction and ridge preservation is a common procedure in the field of Periodontics.  
When extracting non-restorable teeth without ridge preservation of some sort, the alveolar ridge 
will resorb and leave an insufficient amount of bone width and bone height for a final 
restoration.1, 2 
Currently, there are several different graft options routinely used: autografts (bone grafts 
from self), allografts (bone grafts from cadavers of the same species), xenografts (bone grafts 
from differing species), and other bioengineered alloplasts and scaffolds. 
All treatment options have advantages and disadvantages.  Autografts contain “self” cells 
necessary for regeneration, but they require a second surgical site that can lead to post-operative 
pain and complications.3  Allografts are readily available and of unlimited supply, but 
occasionally have variable content from graft to graft which can contribute to unpredictable 
results following augmentation procedures.4,5  Furthermore, there are patients who choose not to 
use cadaveric bone for personal reasons.6,7  Xenografts have similar considerations as allografts.8  
Scaffolds are advantageous over the bone grafts mentioned above as they can theoretically be 
bioengineered individually per clinical situation to have properties that are efficacious in the 
replacement of lost osseous tissue.9  Currently, not all characteristics of the ideal alloplastic bone 
graft substitute have been discovered,9 and it is through experimentation that researchers and 









Structure of Bone 
 
 Osseous tissue is specialized connective tissue composed of approximately one third 
organic and two thirds inorganic elements along with highly specialized cells that regulate its 
stability.10   
The organic matrix of bone consists of primarily collagen type I (90%)11 and 10% non-
collagenous proteins, glycoproteins, proteoglycans, carbohydrates, and lipids.10  The cell 
adhesion proteins, osteopontin and bone sialoprotein, are important for the adhesion of both 
osteoblasts and osteoclasts.12  Other non-collagenous protein includes: osteocalcin, osteonectin, 
bone morphogenetic protein, phosphoproteins, and proteoglycans.13  The principal inorganic 
constituents of the osseous matrix are hydrated calcium and phosphate in the form of 
hydroxyapatite (HA) crystals,10 as well as hydroxyl, carbonate, citrate, and small amounts of 
other ions (sodium, magnesium, and fluoride).14   
Osteoblasts synthesize the organic matrix of bone.  While it is still unmineralized, it is 
known as osteoid.  As the matrix matures, mineral nucleation occurs within the collagen fibers as 
calcium and phosphate are laid down to produce HA crystals.  Non-collagenous proteins on the 
surface of collagen fibers assist in the complete mineralization of the matrix.10   
Mineralization of osteoid typically happens a few days after the laying down of calcium 
and phosphate, however, it takes several months for the maturation to be complete.10  The 
mineralization of bone serves two main purposes; to provide bone with rigidity and strength to 
resist load and protect organs and to store minerals that contribute to homeostasis of the body.10   
 Mature bone is made up of cortical (compact) and cancellous (trabecular) bone.  Within 
the lamellar bone, individual osteons with blood and nerve supply can be observed.15  Osteons, or 







cylindrical structures with haversian (vascular) canals in the center3 and are responsible for 
nourishing the interior bone that cannot be supplied by surface vessels.  They are found primarily 
in the outer cortical plates and the alveolar bone proper.16           
Four different types of cells regulate bone formation, maintenance, and repair: 
osteoblasts, osteocytes, bone lining cells, and osteoclasts.  A sufficient blood supply is necessary 
for the aforementioned functions.  Thus, angiogenesis is a prerequisite for not only bone 
formation, but for maintenance and repair as well.3   
The osteoblast is the primary cell responsible for bone formation.  They produce the 
organic extracellular matrix of bone and control mineralization.10  Osteoblasts are cuboidal cells 
that form a single layer to cover all endosteal and periosteal surfaces where bone formation is 
active.17  Bone growth occurs by the apposition of an organic bone matrix that is deposited 
unilaterally by osteoblasts.   
The osteoblasts lack the capacity for migration and proliferation.  Undifferentiated 
mesenchymal cells and osteoprogenitor cells (present in bone marrow, endosteum, and 
periosteum) migrate to a site and proliferate and differentiate to become osteoblasts.10  This 
differentiation is dependent on growth factors such as bone morphogenetic proteins (BMPs), 
fibroblast growth factor (FGF), insulin-like growth factor (IGF), and platelet-derived growth 
factor (PDGF).10  Osteoblasts may eventually differentiate into two different types of cells, 
osteocytes and bone lining cells.10   
Osteoblasts become osteocytes by inversion of matrix secretion or by entrapment from 
nearby osteoblasts.3  The osteocytes are enclosed in mineralized spaces called lacunae and 
maintain a network of cytoplasmic processes known as dendrites.10  These cytoplasmic 
projections extend into cylindrical compartments referred to as canaliculi.18  The 







survival because diffusion of nutrients and wastes through the mineralized bone matrix is nearly 
impossible.3  The system is also an extracellular and intracellular communication channel with 
neighboring osteocytes, osteoblasts, and bone lining cells.  This communication network is 
sensitive to stress caused by the inflow of fluid resulting from mechanical stimuli and bone 
deformation.10  There are limitations to the canaliculolacunar transport system in mammals, and 
the critical distance to keep osteocytes alive is approximately 100 µm.  This is the reason for 
why wall thickness of osteons in cancellous bone rarely exceeds 100 µm.19     
Osteocytes orchestrate the remodeling processes in bone by translating mechanical 
signals into biochemical mediators that assists in the anabolic and catabolic events that occur.  
These signals are also important in the regulation of blood calcium levels.20   
Bone lining cells are elongated, inactive osteoblasts that cover a large fraction of the bone 
surface.  They are sometimes referred to as inactive or resting osteoblasts.3  These cells are 
located on surfaces that are characterized by having a low modelling activity (resting surface) as 
well as on surfaces where osteoclasts are active.  It is proposed that bone lining cells clean up 
after osteoclasts by engulfing and digesting demineralized bone collagen fibrils protruding from 
resorption lacunae.  This prepares the site for bone apposition by osteoblasts, where they enter 
and lay down a new layer of bone matrix.  Bone lining cells are vital in the sequence of events 
that lead to bone resorption and bone apposition.21 
Bone formation is consistently coupled to bone resorption, and osteoclasts are the 
principal bone resorbing cells.10  They are large, multi-nucleated cells,15 and are a member of the 
monocyte / macrophage hematopoietic family.  The most notable feature of active osteoclasts is 
their ruffled membrane.22  Hydrogen ions and proteolytic enzymes are secreted from the ruffled 
border which dissolve the mineral crystals and degrade the organic bone matrix3 and calcified 







known as Howship’s lacuna.23  Another characteristic feature of osteoclasts are the presence of 
numerous cell surface receptors, including those for receptor activator of nuclear factor kB 
(RANK), macrophage colony-stimulating factor, and calcitonin.3  The activity of osteoclasts can 
be regulated and modified indirectly by parathyroid hormone, or directly by calcitonin.     
 The periosteum is a fibrous sheath that lines the outer surface of long bones (excluding 
articulating surfaces) and the endosteum lines the inner surfaces of all bones.  It is divided into 
an outer “fibrous layer” (dense, fibrous, and vascular) and an inner “osteogenic layer” (loosely 
arranged connective tissue) where osteoprogenitor cells originate from.10  Osteoblasts derived 
from the “osteogenic layer” of the periosteum are responsible for increasing the width and size of 
bones.10  Unlike osseous tissue, the periosteum has nerve endings which makes it sensitive to 
manipulation.  It also allows the passage of blood vessels and lymphatics into and out of bone.10        
 The bone marrow is interspersed within the trabecular bone and consists of hematopoietic 
tissue, stroma cells, and adipose tissue.  Bone marrow is comprised of both red marrow 
(hematopoietic tissue) and yellow marrow (adipose tissue).  It is the major hematopoietic organ 
responsible for the production of erythrocytes, granulocytes, monocytes, lymphocytes, and 
platelets.10  The stroma contains mesenchymal stem cells that can differentiate into a variety of 
cell types such as: osteoblasts, chondroblasts, adipocytes, myocytes, beta-pancreatic islet cells, 





 During embryogenesis, bones of the skeleton form either by a direct or an indirect 







center develops directly by mesenchymal condensation.  The extracellular matrix matures, and 
osteoprogenitor cells differentiate into osteoblasts.  As appositional growth occurs, osteoblasts 
become entrapped in the mineralizing matrix giving rise to the osteocyte lacunocanalicular 
network.10  The skull, mandible, maxilla, and clavicle are all formed directly through 
intramembranous osteogenesis.   
 In a process known as endochondral osteogenesis, bones develop indirectly by a 
cartilaginous template that becomes mineralized, later is resorbed, and ultimately is replaced by 
bone.10  This leads to the formation of primary and secondary ossification centers that are 
separated by cartilaginous growth plates.10  The long bones, mandibular condyle, and vertebrae 
are all formed indirectly through endochondral osteogenesis.10   
 
The Alveolar Process and the Alveolar Bone Proper 
 
 The alveolar process is the portion of the maxilla and mandible that forms the dental 
sockets (alveoli).16  It forms in harmony with the development and eruption of teeth, and it also 
disappears gradually after the loss of teeth.24,25  The alveolar process consists of an external plate 
of cortical bone (formed by haversian bone and compacted bone lamellae) and an inner socket 
wall of thin, compact bone, called the alveolar bone proper.  The alveolar bone proper is seen in 
radiographs as the lamina dura.16   
 At sites on the ridge where teeth erupt in a “normal” position, hard tissue will be present 
on both the buccal (facial) and lingual (palatal) aspects of the root.  However, when teeth erupt 
with a more buccal (facial) inclination, the alveolar process will be thin and possibly non-







the bone varies considerable from subject to subject and from site to site within the same 
individual.24             
The tooth and surrounding tissues (the cementum, periodontal ligament, and bundle 
bone) form a functional unit.  Therefore, forces occurring during mastication are transferred from 
the crown of the tooth, down the root, to the soft tissue attachment, and finally dispersed to the 
surrounding load-carrying osseous tissue.24       
 
Healing of Bone: Repair and Regeneration 
 
Repair is the healing of injured tissue that leads to the formation of new tissue that is 
different in morphology and function from that of the original.  Regeneration is the replacement 
of lost tissue so that structure and function are fully restored.  Regeneration can be divided into 
physiologic regeneration and reparative regeneration.3  The healing of osseous tissue usually 
includes both repair and regeneration depending on the injury.10     
 When bone is damaged, a multistage healing process begins to facilitate repair.  Tissue 
and cell proliferation are mediated by various growth factors, inflammatory cytokines, and 
signaling molecules.10  Bone repair can be divided into three phases: inflammation, reparative, 
and remodeling.26   
 Immediately after tissue injury, the inflammation phase begins and lasts approximately 
two weeks.27  The first step in the repair process is formation of a blood clot.  Injured cells then 
release cytokines to recruit inflammatory cells, allowing for damaged tissue and cells to be 
phagocytized by macrophages.  Cells from myeloid and mesenchymal cell lineages are also 
recruited to the injury site where they begin to differentiate into osteoblasts and chondroblasts.  







 During the reparative phase, osteoblasts and chondroblasts produce a protein scaffold that 
initially forms a soft callus, eventually becoming mineralized to form a hard callus.  The hard 
callus is comprised of immature wove bone.  The formation of the hard callus is mediated 
through up regulation of interleukin 6 (IL-6), OPG, vascular endothelial growth factor (VEGF), 
and BMPs.  It takes approximately six to twelve weeks to transition from soft to hard callus 
following bone injury.10        
 During the final remodeling stage, the woven bone matrix and cartilage are remodeled 
into mature lamellar bone.  This is done through normal bone turnover from osteoblast-osteoclast 
coupling.  The time for remodeling varies depending on an individual’s bone metabolism, but 
usually requires months from the injury.10     
 Bone is a dynamic tissue that is constantly remodeled in response to mechanical loading, 
serum calcium levels, and in response to multiple paracrine and endocrine factors in a process 
known as physiologic regeneration.  This process occurs in both cortical and cancellous bone.28 
 Reparative regeneration replaces tissues that are lost to injury or disease.  Osseous tissue 
has a remarkable regenerative potential to restore its original mechanical properties and 
architecture.  The reconstruction of the original tissue occurs sequentially and closely repeats the 
pattern seen during development and growth.  There are challenges to this process such as 
needing sufficient blood supply, having mechanical stability, and competing with other tissues of 
highly proliferative activity.3     
 Bone lesions activate localized bone regeneration by the release of growth factors and 
other signaling molecules.  In orthotopic bone formation, osteoprogenitor cells from nearby bone 
marrow stroma, periosteum, endosteum, and intracortical canals respond to the inductive signals 
and proliferate and differentiate into osteoblasts.  The lag phase is roughly one to three days, and 







There are two steps in the regeneration of bone, osteogenesis, the predominant factor, and 
resorption.  Resorption removes damaged and necrotic bone and remodels newly deposited bone, 
particularly in the conversion of immature woven bone to mature lamellar bone.29  This process 
involves osteoblastic-osteoclastic coupling of bone formation and bone resorption in a “basic 
multicellular unit” (BMU).28  In BMUs, osteoclasts first resorb bone over a period of three to 
four weeks.  Cellular signals are then sent to osteoblasts to be recruited to the area.  It takes 
osteoblasts roughly three to four months to reform the bone.10 
 Treatment to promote bone regeneration include bone grafting from different materials, 
epithelial-occlusive barrier membranes, anabolic agents, anti-resorptive agents, and growth 
factors to promote osteoblastic differentiation and proliferation.10     
 
Dimensional Changes Following the Extraction of Teeth 
 
 The loss of teeth will result in a series of adaptive changes in the newly edentulous site of 
the ridge.  Pietrokovski and Massler (1967) studied the dimensional changes in the ridge 
following the removal of a single tooth.  They looked at dental casts where one tooth was 
missing on one side of the jaw.  They concluded that the amount of hard and soft tissue 
resorption following the loss of a single tooth was significant and that the reduction of the ridge 
was twice as big on the buccal or facial aspect as it was along the lingual or palatal aspect in all 
sites studied.  Tissue modeling shifted the center of the edentulous site towards the lingual or 
palatal aspect of the ridge.1  Similar findings were found by Schropp et al. (2003).  Through the 
use of dental stone casts and clinical examinations, they observed the hard and soft tissue 
changes following the extraction of premolars and molars over the course of a year.  They found 







twelve months it was reduced by 50% of the original width.  Furthermore, the vertical height of 
the buccal bone was also reduced.2   
 The amount of buccal bone resorption is also dependent on the thickness of the buccal 
plate.  In early resorption studies of less than four months, Sanz et al. (2010) observed that 
buccal plates that were less than 1 mm wide had substantially more dimensional changes 
horizontally and vertically than buccal plates that were greater than 1 mm.30  One must also 
consider that buccal bone in the anterior region is frequently less than 1 mm wide.31  As 
exemplified through CBCT analysis, Kan et al. (2011) has shown that 81.1% of all maxillary 
anterior roots are positioned against the labial cortical plate, and 0.7% of the time maxillary 
anterior roots are positioned against the palatal cortical plate.32  Therefore, it can be anticipated 
that if there is tooth loss in the anterior region, marked dimensional change in the horizontal and 
vertical dimensions will occur, and that will cause esthetic concerns.24   
 
Alterations that Occur in the Alveolar Process Following Extraction 
 
The earliest studies of the healing response following dental extractions used the animal 
canine model.  Schram (1929) used dogs with sound dentition in his experiment to study the 
repair process following surgical intervention in the maxillary dentition.  The maxillary first 
premolars were removed by simple forceps extraction.  The animals were euthanized at various 
times, and the extraction sites were studied histologically.  In looking at the simple extractions at 
eight days, the socket was filled with a blood clot, and the surface was completely covered with 
epithelium.  Connective tissue extended from the bony walls of the socket, and the central part of 
the clot contained red blood cells in all stages of degeneration.  Schram noted absorption taking 







days, the connective tissue projecting from the bottom and sides of the socket was calcified and 
had been converted into new spongy (cancellous) bone.  At twenty-one days, the socket was 
almost completely filled with cancellous new bone while some remnants of the original clot 
remained in the center of the wound.  At forty-eight days, the rebuilding of the socket was 
essentially complete.33 
Claflin (1936) also looked at histologic findings concerning the undisturbed healing of 
extraction wounds in dogs and came up with similar observations and conclusions.  The 
formation of a blood clot was the first step in tissue regeneration and healing.  Fibroblasts began 
to proliferate into the blood clot by the end of the third day.  Osteoclasts were also found at the 
alveolar crest on the third day.  Bone regeneration was first noted in the apical one third of the 
socket beginning on the fifth day, and the sockets were completely filled with new bone thirty-
one days after extraction.  Osteoclastic action was also still seen taking place below the 
cribriform plates of the socket after the extraction wound had healed for thirty-one days.34     
Cardaropoli et al. (2003) provided some of the most in-depth detail of the phases of 
socket healing, including modeling and remodeling, in the dog model.  Nine mongrel dogs were 
used in the study.  The distal root of the mandibular fourth premolars were extracted, and 
biopsies of the experimental sites were taken at various times up to six months.35  It is important 
to note that the phases of healing in the dog model are more rapid than that in humans.  The 
authors saw that oftentimes the socket was completely healed within two to three months.24   
Blood from severed vessels immediately filled the socket following extraction.  Proteins 
from the damaged cells and vessels led to the formation of a fibrin network which entrapped 
erythrocytes and platelets to form a clot.35  The blood clot acted as a physical matrix that directed 
cellular movement.  The blood clot also contained growth factors that were important in the 







removal was necessary to allow the formation of new tissues.  Within a few days following 
extraction, the blood clot was broken down in a process called fibrinolysis.24  
During days one to three, neutrophils and macrophages migrated to the extraction socket 
to rid the site of damaged cells and bacteria before new tissue could be formed.  The 
macrophages also released growth factors and cytokines that promoted the migration, 
proliferation, and differentiation of mesenchymal stem cells.24  Once the site had been cleansed, 
the neutrophils underwent apoptosis (programmed cell death) and were removed by  the 
macrophages.  The macrophages then exited the site.24               
After three days, the blood clot had been replaced by granulation tissue.  The granulation 
tissue was comprised of vascular structures and fibroblast-like cells from the bone marrow and 
periodontal ligament.35  After seven days of healing, the wound had undergone marked 
changes.35  During this time, the fibroblast-like cells released growth factors, had proliferated, 
and deposited a new extracellular matrix (fibroplasia) that guided the ingrowth of cells.  The 
vascular structures expanded (angiogenesis) and provided the oxygen and nutrients needed for 
increasing the number of new cells in the tissue.  Fibroplasia and angiogenesis were needed to 
establish a provisional connective tissue that replaced the granulation tissue.24  
After fourteen days of healing, the marginal portion of the socket was lined by connective 
tissue that was rich in vasculature and inflammatory cells.35  Osteoprogenitor cells migrated to 
these vessels and differentiated into osteoblasts to produce the osteoid.  As osteoblasts continued 
to lay down bone, these cells became entrapped within the matrix eventually becoming 
osteocytes.  The first set of osteons, the primary osteons, were organized in the newly formed 
woven bone.24 
At thirty days of healing, it was observed that the marginal soft tissue harbored a fibrous 







woven bone (primary bone spongiosa) that was continuous with the old bone of the extraction 
socket walls.35  The primary bone spongiosa was important for tissue modeling because it 
offered a stable scaffold, a source of osteoprogenitor cells, and an ample blood supply.  At this 
point, the initial phase of healing, tissue modeling, was now complete.24 
At sixty days of healing, it was observed that woven bone with its primary osteons had 
been replaced with lamellar bone and bone marrow through the actions of BMUs.  Osteoclasts 
created a resorption front known as the reversal line, and it was from this line that new bone was 
formed with secondary osteons.  It took several months until all woven bone in the extraction 
socket had been replaced by lamellar bone.24  
Healing became complete by the formation of a hard tissue cap that closed the entrance to 
the socket.  The cap was initially comprised of woven bone but was later remodeled and replaced 
by lamellar bone to become continuous with adjacent cortical bone in a process known as 
corticalization.24  The site continued to adapt to functional demands, and since it was not subject 
to forces of mastication and occlusal contacts, it was remodeled mainly into marrow.24            
Huebsch et al. (1952) examined the healing response radiographically as well as 
histologically after the simple extraction of mandibular left first molars in the Long-Evans strain 
of rats.  They came up with the following observations: the blood coagulum began twenty-three 
hours after the extraction by evidence of capillary ingrowth.  Fibrocytes invaded the socket three 
days after extraction and began forming immature connective tissue.  Initial bone formation was 
seen on the fifth day in the fundus of the alveolus.  By the thirteenth day, young bone almost 
completely filled the socket.  On the twenty-fifth day, new bone had formed a cortical layer 
between the lingual and buccal crests.  By this time, bone healing had been complete.  Bone 
formation was first visible radiographically on the sixteenth day at the apical portion of the 







following extraction, the socket showed a homogenous continuity with the adjacent part of the 
mandible.  Huebsch et al. found the characteristics of histogenesis of repair to be in accordance 
with observations of other species.36 
Glickman et al. (1947) studied the effects of extraction socket healing when leaving root 
remnants or bone fragments in the rat model.  Much of the previous studies focused on 
uncomplicated extraction healing.  Glickman et al. wanted to observe what happens when 
complications arise.  Glickman et al. extracted the maxillary right first molar only, leaving some 
root remnants behind in fourteen rats and compared it to four rats where they extracted all crown 
and root remnants of the maxillary right and left first molars.  The rats were sacrificed at varying 
time points up until one hundred and eight days.  They concluded that retained root remnants and 
bone fragments slow the progress of post-extraction healing by interfering with surface closure 
and / or secondary inflammatory changes.  Of note is that it is the position of the root remnant in 
relation to the surface which determines the response of the adjacent tissues.  Root remnants 
deep in the wound are generally well tolerated by the surrounding tissues, whereas remnants 
close to the surface prevent epithelial closure by increasing inflammation.  Glickman et al. 
however noted that with deep root remnants, there could be pathologic changes in the presence 
of an intact healed epithelial surface that makes the retention of theses root remnants 
undesirable.37     
Steinhardt (1932) studied the histology in human jaws obtained at necropsy and made 
comparisons to the healing sequence of other animal models.  Steinhardt reported his findings on 
three subjects with known time of elapse from extraction to death.  The first patient died three 
weeks after extraction of his teeth.  Steinhardt observed that the wounds were covered with 
epithelial tissue, the sockets were filled with young granulation tissue, and the fundi with 







second patient died three and a half months after extraction of a lower bicuspid.  The depth of the 
socket was reduced by the presence of new bone, the epithelium had covered the wound 
completely, and the central portion of the socket contained remnants of the original blood clot.  
Steinhardt stated this would correspond to an eight-week-old extraction in a dog.  The third 
patient had a lower second molar extracted six weeks before death.  The socket revealed new 
bone formation and was filled with granulation tissue.  Epithelium had only partially covered the 
socket.38  In reviewing Steinhardt’s 1932 paper, Claflin (1936) concluded that the human healing 
processes in extraction wounds are the same as in dogs, but they occur at a slower rate.34       
Amler et al. (1960) studied socket healing following dental extractions in healthy human 
beings at two- to three-day intervals up to a period of fifty days.  They observed that the same 
histochemical reactions seen for histogenesis of bone observed in animal studies were also found 
in human alveolar socket healing.  Amler et al. observed the following healing sequence:  by 
twenty-four hours, blood clot formation filled the entire alveolar socket.  At two to three days 
post-extraction, granulation tissue then began to arise from the periphery of the socket.  This 
granulation tissue was accompanied by a metachromatic ground substance, glycoprotein, and 
alkaline phosphatase.  The granulation tissue invaded the blood clot and replaced it by the 
seventh day.  By the fourth day, young connective tissue was found at the periphery along with a 
metachromatic ground substance, alkaline phosphatase, and a glycoprotein framework.  
Connective tissue encroached upon the granulation tissue and replaced it by the twentieth day.  
Also, epithelialization was evident and associated with glycogen and glycoprotein on the fourth 
day.  Bone formation was first seen at the base of the socket on the seventh day and at least two 
thirds of the socket was filled by the thirty-eighth day.39   
Amler et al. noted the following factors to affect the time for complete epithelialization: 







alveolar crest, 5) foreign bodies in the socket (bone particles or root splinters).  They classified 
these as normal factors to affect healing.  They also noted the following pathologic factors that 
could affect complete epithelialization: 1) periodontal condition (pre-operative), 2) local 
infection (post-operative), 3) nutritional and systemic factors.39      
Amler et al. (1960) was of short duration and only evaluated healing events that took 
place in the marginal portion of the socket.  Their research also did not include the healing 
processes of remodeling that occur in the later phases of socket healing.  It is this reason that the 
tissue composition of the fully healed extraction socket could not be documented.24   
In a longer-term study of six months, Trombelli et al. (2008) examined socket healing in 
humans.  They confirmed most of the early healing findings from Amler et al. (1960).  In 
biopsies taken from later samples, they saw that when woven bone was replaced by lamellar 
bone, the process of remodeling, it was slow and varied greatly from individual to individual.  In 
only a few of the specimens at six months had woven bone been replaced by trabeculae and bone 
marrow of lamellar bone.  They concluded that the modeling process that occurs during the first 
weeks of healing is consistent, but the interval during which remodeling takes place is slow and 
may take several years to complete.40   
Lindhe et al. (2012) studied human biopsy samples from the bony part of edentulous 
ridges to examine their composition.  Core samples were taken from subjects prior to implant 
placement with fully healed edentulous regions.  What they found was that the peripheral borders 
of the ridge were lined with dense cortical bone.  The central portion consisted mostly of 
cancellous bone with trabeculae of lamellar bone embedded in bone marrow.  The composition 
of the samples was roughly 47% lamellar bone, 8% woven bone, 4% osteoid, 17% bone marrow, 







After the extraction of a tooth, sockets heal by secondary intention, and it takes many 
months before it becomes difficult radiographically to distinguish the extraction socket from the 
surrounding bone.42  Schropp et al. (2003) studied bone formation in single extraction sockets 
using subtraction radiography at baseline, three, six, and twelve months post-extraction.  All 
radiographs were standardized.  What they found was that initially, vertical bone loss took place 
in the alveolar crest region.  Most bone gain in the socket occurred in the first three months, with 
some additional gain in months three to six.  Remodeling was seen between months six and 
twelve with the amount of mineralized tissue being reduced.2  As evident by many students, the 
initial phases of healing follow a pattern, but the later phases of remodeling varies from 
individual to individual.      
 
Bone Grafting and Bone Grafting Substitutes 
 
Bone grafting has been attempted for centuries with varying degrees of success.8  There 
are a variety of clinical scenarios in which bone grafting has been used such as: replacing 
portions of bone in reconstructive surgery, repairing osseous defects through osteoconduction, 
stabilizing blood clots, providing mechanical membrane support, and serving as a vehicle for 
growth factors.3  The ideal bone grafting materials are those that fulfill the following 
requirements: safe and non-toxic, biocompatible, become osseointegrated or replaced, provide 
mechanical support and act as an osteoconductive scaffold, allow the ingrowth of vasculature, 
and are relatively inexpensive and readily available.3     
There are several types of grafts used in regenerative therapy: autograft (from self), 
allograft (from the same species), xenografts (from other species), alloplasts (from man-made 







properties: osteoconductive, osteoinductive, and osteogenic.  Because of their source and the 
preparation used to avoid a rejection reaction in the host, the grafts have different qualities and 
different indications for use.    
Osteoconductive materials are those that have a matrix that serves as a scaffold for bone 
deposition.  Osteoinductive materials have proteins that stimulate and support the proliferation 
and differentiation of osteoprogenitor cells that later become osteoblasts.  Osteogenic materials 
are those that contain osteogenic cells (osteoblast and osteoclast precursors) that when placed in 
the proper environment are capable of forming bone.3   
Induction of bone formation requires three elements: soluble osteoinductive signals, cells 
that are able to respond to these and other signals, and a supporting matrix or scaffold to carry 
and deliver cells or growth factors.3  BMPs are the only growth factors that have true 
osteoinductive properties.  Other growth factors such as PDGF, VEGF, FGF, growth hormone 
(GH), and insulin-like growth factor (IGF) do not have true osteoinductive properties, but do 
play a role in enhancing bone repair and regeneration.     
 When a graft is transplanted from one site to another in an individual, immunologic 
complications usually do not occur because the tissue is recognized as “self”.  This is not the 
case when tissue is transplanted from one individual to another or from one species to another.  
The immune system may create a challenge for the success of the grafting procedure.  If the graft 
tissue is recognized as a foreign substance, the host’s immune response will try to destroy the 
graft.  The host’s immune response is typically a cell-mediated response by T lymphocytes.  
Often times, the response does not occur immediately after implantation, and at first it may 
appear as if the graft is integrating normally only to be attacked later on.  The more similar the 







 There are two methods used clinically to prevent immunologic rejection of transplants 
and improve the chances of success in grafting procedures.  The first method is the suppression 
of the host’s immune response.  Medications are commonly used in organ transplant patients to 
prevent the host’s rejection of the new organ.  This is however not commonly used in periodontal 
surgery procedures due to the risk of immunosuppression.8  The second method, and one that is 
commonly used in periodontal surgery procedures, is altering the antigenicity of the graft so that 
it does not stimulate the host’s immune response.  There are several methods to treat the graft, 
and they include: deproteinization, freezing, freeze-drying, irradiating, and dry heating.8   
 
Types of Grafts 
 
 Autografts, or self-grafts, are grafts taken from tissues of the same individual.  Fresh 
autogenous bone grafts are the most ideal bone grafts available because they provide living, 
immunocompatible bone cells that are essential to osteogenesis.  The amount of osseous tissue 
produced is directly related to the number of living cells that are transplanted.8  
 The bone can be taken from a variety of sites in the body.  Block grafts are usually taken 
from the iliac crest, and contain both cortical and cancellous bone.  Ribs can also be a source for 
block grafts.  Cancellous bone and particulate marrow can be obtained from harvesting 
medullary bone and hematopoietic marrow.  Cancellous bone and particulate marrow provide the 
greatest concentration of osteogenic cells.  Furthermore, because of the particulate size, these 
grafts are more likely to survive transplantation because of their access to nutrients in the graft 
bed.  This type graft is most often obtained from the ilium.8   
There are two basic processes that occur when transplanting bone from one place to 







cells in the graft that form new osteoid.  The amount of bone regeneration is dependent on the 
number of transplanted cells that survive the grafting procedure.  There are many cells that die 
during the transplantation process, and because of this, there may not be an abundant amount of 
bone regeneration.  These cells depend on diffusion of nutrients from the surrounding area for 
survival due to the interrupted blood supply that results from transplantation.  This phase is 
responsible for most of the newly regenerated bone.8 
 Beginning in the second week, the graft site also undergoes changes that leads to the 
second phase of bone regeneration.  During this time, fibroblastic proliferation and new blood 
vessel formation from the graft bed begins.  The fibroblasts and other mesenchymal cells 
differentiate into osteoblasts and begin to lay down new bone.8  According to Urist (1972), there 
are several BMPs in the grafted bone that cause these changes to occur in the surrounding 
tissues.43  The second phase of bone regeneration is responsible for the incorporation of the graft 
into the host with continued resorption, replacement, and remodeling of the bone.8             
Advantages to using autografts are that they contain osteoconductive, osteoinductive, and 
osteogenic properties3 and that no immunologic response occurs with their use.8  Disadvantages 
to using autografts are that they may be of limited quantity and necessitate a second surgical site 
for obtaining a graft.8  This second surgical site increases operative time and cost, pain, intra-
operative blood loss, and recovery time.3 
 Allografts, or homografts, are grafts taken from members of the same species, and 
transplanted into a host.  They are available with a variety of biologic properties and also 
available in many forms: mineralized bone matrix, demineralized bone matrix, cortical chips, 
cancellous chips, corticocancellous chip, osteochondral, and whole-bone block segments.7  These 
grafts are often treated to reduce the antigenicity because the donor and the host are genetically 







leads to the destruction of any remaining osteogenic cells in the graft.  Because of this, allogenic 
bone grafts cannot participate in the first phase of osteogenesis.  They do however offer an 
osteoconductive hard tissue matrix for phase two of induction.  The host must produce all 
essential elements in the graft bed for the transplanted graft to be resorbed and replaced.8  
Allografts can be used in combination with autologous grafts when supply of autologous bone is 
limited to fill larger voids.7  In fact, some of the most successful grafts are mixtures of 
autologous bone marrow and demineralized bone matrix.44   
 Demineralized bone is a commonly used allograft that is well suited for filling bone 
defects and cavities.45  It has osteoconductive and osteoinductive properties and revascularizes 
quickly.7  The osteoinductive capacity of demineralized bone is attributed to the activity of 
BMPs46 present in the extracellular matrix that are made available to the host during the 
demineralization processing.7  The osteoinductive capacity differs from donor to donor.  Because 
of this, the United States Food and Drug Administration and American Association of Tissue 
Banks mandate that each batch of demineralized bone matrix be obtained from a single donor.6  
 Currently, the most commonly used allogenic bone is freeze-dried.8  The freeze-drying 
and vacuum-packing preservation technique allows for the graft to undergo stages of 
incorporation similar to that of autogenous cancellous bone.7  Freeze-dried allografts are 
osteoconductive and provide mechanical support.  They are most beneficial when used in 
combination with autologous grafts to fill larger defects.7  
 Fresh allografts that require no preservation are also available.  These grafts invoke an 
intense immunological reaction and have limited applications.  Currently, they are mainly used 
for joint resurfacing.7      
 Advantages to using allografts are that they do not require a second surgical site in the 







replaced.8  Disadvantages to using allografts are that the grafts do not provide viable cells to 
participate in phase one of osteogenesis.8  There is also a very small risk in infectious disease 
transmission through the use of allografts.7  However, in the three million allograft tissue 
transplants performed since the identification of the HIV virus, only two cases of HIV 
transmission have occurred, and these involved the use of fresh-frozen allografts.6        
 Xenografts, or heterografts, are grafts taken from differing species8 or bone-like minerals 
derived from calcifying corals or algae9 and transplanted into a host.  Most animal-derived 
xenograft bone sources are bovine, porcine, or equine.  The antigenic dissimilarity is much 
greater than that seen in an allograft.  It is because of this dissimilarity that xenografts are treated 
more vigorously to prevent rapid rejection of the graft by the host.8 
 Anorganic bovine bone (ABB), such as Geistlich Bio-Ossâ, is bovine bone that has been 
chemically treated to remove its organic components.  It is biocompatible and has a trabecular 
and porous architecture similar to that of human bone.47  It has been proposed that this bone graft 
has no osteoinductive properties but serves as an osteoconductive scaffold for new bone 
formation.47  However, the processing has a strong influence on the graft’s biologic behavior.9   
There is controversy as to whether deproteinized bovine bone mineral (DBBM) is truly 
resorbable.4  Human biopsies after sinus augmentation confirm that particles of bovine-derived 
bone substitutes can be found ten years post-operatively.4  Xenografts must be selectively used 
as they are considered close to non-resorbable.9   
Coralline calcium carbonates are processed natural coral skeletons (NCSs) that can serve 
as a resorbable bone graft substitute.  Different species of calcifying coral were found to have a 
calcium carbonate skeleton with interconnected macropores similar to that of human cancellous 
bone.9  The coralline calcium carbonate is transformed into HA by a hydrothermal exchange 







bone.9  The material acts as an osteoconductive scaffold for the formation of new bone47 
although the osteoconductive potential is less than that of other bone graft substitutes.5  NCSs 
enhance osteoblastic cell attachment and growth,48 and this bone replacement graft material has 
shown long-term (5+ years) favorable clinical results in the treatment of periodontal osseous 
defects associated with moderate to advanced adult periodontitis.49  Today, coralline HA are 
rarely used as onlay grafts in guided bone regeneration (GBR) procedures because of a high rate 
of late complications.50  
 Advantages to using xenografts are that they do not require a second surgical site in the 
host.  Also, large quantities of the xenograft can be obtained.8  Disadvantage to using xenografts 
are that the grafts do not provide viable cells to participate in phase one of osteogenesis and that 
they must be vigorously treated to reduce antigenicity and host rejection.8            
Alloplasts are synthetic grafts or inert foreign bodies that are transplanted into a host.47  
They consist of ceramics, biocompatible composite polymers, and bioactive glass ceramics.  
Alloplastic bone graft substitutes are becoming more popular.  They have osteoconductive 
properties of varying degrees and can be used to fill large defects.3  However, two conditions 
must be met for successful osteoconduction: the scaffold must consist of a bioactive or bioinert 
material, and the shape of its external and internal surfaces should favor tissue ingrowth and 
bone deposition.3  A material resembling spongious bone in terms of shape and dimension 
provides the ideal condition for angiogenesis that allows for bony ingrowth.51  These materials 
have shown limited effectiveness in treating osseous defects around teeth, however they have 
been shown to be effective in procedures such as alveolar ridge preservation and ridge 
augmentation.47   
Ceramics consist primarily of beta tricalcium phosphate (b-TCP) and HA.47  HA is an 







directly on its surface without any intervening layer of fibrous tissue.53  The particles of HA can 
be either large or small, and dense or porous.  The density determines the compressive strength 
and the extent of vascular ingrowth.  Typically, larger particles are non-resorbable whereas 
smaller particles are resorbed rapidly.  Larger particles are commonly used in ridge preservation 
and augmentation procedures, and smaller particles are used in periodontal defects.47  b-TCP is 
similar to HA in that its resorption rate depends on both particle size and porosity.  Human 
histologic studies have shown that when HA and b-TCP have been used in treating periodontal 
defects, there is resulting fibrous encapsulation of the graft material and pocket closure is 
achieved through long junctional epithelium,54,55 indicating that ceramic fillers are unable to 
result in true regeneration.47   
Biocompatible composite polymer, also known as “hard tissue replacement’ is composed 
of poly-methylmethacrylate-poly-hydroxyl-ethyl-methacrylate beads coated by calcium 
hydroxide.  When introduced into the body, the calcium hydroxide surface forms a calcium 
carbonate apatite.47  Hard tissue replacement has been shown to be more effective than 
debridement alone in treating intra-osseous defects56 and class II furcation defects,57 but 
inconsistently promotes new attachment as seen through histology.58     
Bioactive glass ceramics are made up of CaO, Na2O, SIO2, and P2O5 in the same 
proportions as in bone and teeth and are referred to as 45S5 bioactive glass.47  These silica-based 
materials were first introduced in the early 1970s.9  The material was original introduced as an 
amorphous material (Bioglass).47  Earlier primate studies with this material demonstrated bone 
and soft tissue regeneration around teeth.59  The material was later produced in particulate form 
of varying diameters (PerioGlas and BioGran).47  When the material comes in contact with body 
fluid, there is an ionic dissolution of the ceramic particles which allows a silica gel layer to form 







rapidly converted to a hydroxycarbonate apatite layer.60  Studies have shown that this apatite 
layer is identical to bone mineral and it provides a surface for osteoblast cell attachment and 
bone deposition.61  In a study Low et al. (1997) using bioactive glass ceramics in combination 
with debridement of intraosseous defects, the results indicate that statistically significant 
improvements were seen in probing depth reduction, clinical attachment level gain, and 
standardized radiographic comparisons, and these results remained stable over the course of two 
years.62  Limitations of the Bioglass products are that they cannot reliably serve as space-
maintaining devices because of their granular and non-porous nature.63  
In order for a scaffold to be effective in tissue engineering, it must satisfy the following 
demands: be able to fit into an anatomic defect, possess mechanical properties that can bear in 
vivo loads, enhance tissue in-growth, and produce biocompatible degradation byproducts64 to 
avoid the need for later surgical removal.  The scaffold should also have an internal spatial 
structure of appropriate pore size and interconnectivity that allows for communication with cells 
dispersed within the scaffold.65  Shaping the three-dimensional scaffold so as to precisely fit the 
irregular bone defect is limited to mold shape, post-fabrication shaping, and complex computer-
aided fabrication techniques.66,67  Because of this, scaffolds that form in situ (i.e. injectables) 
have been explored.68  Many of these hydrogels lack the mechanical strength69 and the 
cytotoxicity of the reagents may be problematic.70  Also, in situ forming hydrogels often lack 
adequate pore size and the interconnectivity that limits cellular migration and subsequent 
degradation.71  Thermoresponsive shape memory polymers (SMPs), such as Poly(e-
caprolactone) (PCL)-based SMP, was fabricated to “self-fit” into irregular cranio-maxillofacial 
defects.72   
Poly(e-caprolactone) (PCL)-based SMP have attracted attention72 because they are an 







repair of osseous defects.64  These scaffolds are prepared in such a way that allows them to be 
manually compressed into an irregular shaped defect, and their expansive shape recovery occurs 
until the defect boundaries are met.73  Shape memory behavior and pore interconnectivity were 
made possible through the unique fabrication process.73  In addition, the PCL SMP can also be 
coated with a bioactive polydopamine coating that increases hydrophilicity and bioactivity.  This 
can ultimately enhance HA formation in vivo.74,75            
Advantages to using alloplastic grafts and scaffolds are they bear no risk of disease 
transmission because of their completely synthetic nature.  Also, every material characteristic 
can theoretically be designed individually for a specific clinical indication.9  Short-comings of 
the materials are that not all characteristics of the ideal alloplastic bone graft substitute have been 
identified.9  Furthermore, technical limitations have made it impossible to design desired 
material characteristics such as a microporous material with a surface roughness that stimulates 




 GBR, the combination of a bone graft material and a barrier membrane, is one of the 
most widely used methods to augment bone in the oral cavity.  Hurley et al. (1959) were the first 
to study the application of a barrier membrane to promote bone regeneration in orthopedic 
research in canines.  They found that the use of a porous HA Millipore (an inert cellulose acetate 
plastic) barrier prevented the transmigration of cells while permitting the diffusion of 
extracellular fluids.  They concluded that HA Millipore barrier membranes would be a valuable 
tool in osteogenesis.76  The key principle behind GBR is to exclude the faster growing fibroblasts 







membranes, osteoprogenitor and stem cells are allowed to differentiate into osteoblasts in the 
coagulum and begin the process of laying down a bone matrix.    
 In a human study, Nyman et al. (1982) were the first to use the Millipore filter on a single 
tooth with advanced periodontal disease planned for extraction.  Flaps were laid, the site was 
debrided, and a Millipore filter was placed over the defect.  Three months later, the tooth was 
block sectioned and the sample was prepared for histology.  What they discovered was that new 
cementum was found coronal to the initial defect site, and that the Millipore filter prevented the 
apical downgrowth of dentogingival epithelium.77  Guided Tissue Regeneration (GTR) in the 
mouth was shown to be effective by using a barrier Millipore filter.      
 Dahlin et al. (1988) also studied how bony defects heal by GTR.  They created 
standardized through and through 5 mm diameter defects with trephine burrs on both sides of a 
rat mandible.  On one side of the jaw, the through and through defect was covered with a porous 
polytetrafluoroethylene (PTFE) membrane that extended 3 mm past the edges of the defect on 
both the buccal and lingual side.  The other side received no membrane and served as the control.  
The rats were sacrificed at various time points throughout the experiment.  What they discovered 
was that by the use of a PTFE membrane, virtually complete osseous healing had occurred by 
three weeks, whereas on the non-membrane side, connective-tissue ingrowth had prevented bone 
healing even after twenty-two weeks of observation.  They concluded that a mechanical 
hindrance to soft tissue proliferation into a bone defect is a benefit for unimpeded bone healing.78  
This is one of the earliest studies to demonstrate that a chemically inert Teflon membrane was 
effective in GTR.     
 Non-resorbable membranes are highly effective in GTR and guided bone regeneration.  
The downside to using such materials is the need for a second surgery to remove, and this puts 







biodegradable materials,79 the collagen membrane.  Numerous studies have been conducted that 
have shown collagen membranes are effective in gingival connective tissue and epithelial 
exclusion.80,81  Collagen membranes have been shown to be incorporated within the healing 
tissues by ingrowth of the host’s fibroblasts and blood vessels with minimal inflammatory 
reactions.82  The collagen membranes have also been shown to be degraded during the healing 
process82 via the patient’s own collagenase enzymes.79  These properties make collagen 
membranes an effective material in GTR.  
 The question now becomes, is there a significant difference in the use of non-resorbable 
versus resorbable membranes in treatment?  Blumenthal (1993) compared the effectiveness in 
treating mandibular class II buccal furcation defects with either resorbable collagen membranes 
or non-resorbable e-PTFE membranes over the course of a twelve-month healing period.  
Blumenthal discovered that both materials were effective in gaining vertical and horizontal 
probing new attachment and concluded that the intrinsic properties and ease of handling made 
collagen membranes a feasible alternative in GTR.79  Cortellini et al. (1996) also compared the 
use of bioresorbable membranes and non-resorbable e-PTFE membranes against open flap 
debridement alone in the treatment of deep interproximal Intrabony defects.  They concluded that 
clinically significant clinical attachment level gains can be obtained with GTR procedures using 
both bioresorbable and non-resorbable membranes.  However, the patient’s morbidity was lower 
in the group treated with bioresorbable membranes.83     
 It has been thoroughly discussed that tooth extraction (or loss) results in alveolar ridge 
resorption.  Therefore, clinicians should intervene at the time of extraction to preserve as much 
alveolar bone as possible.  In an experimental animal study, Becker et al. (1995) showed that by 
using a non-resorbable e-PTFE barrier membrane, more original bone volume could be 







coverage alone.84  Several human studies have also shown the clinical effectiveness of using 
non-resorbable e-PTFE membranes85 and bioabsorbable membranes86 in preserving alveolar 
ridges following tooth extraction based on the principles of GBR.  These studies demonstrated 
that the use of membrane barriers resulted in minimal resorption of the alveolar ridge in both size 
and shape.87        
 In most of the earlier studies that treated extraction sockets using a membrane, they were 
performed without achieving primary closure of the flap (i.e., an exposed membrane that covered 
a grafted socket).  More recent studies have indicated that more bone fill may be obtained by 
primary closure of the flap over the barrier membrane because early exposure hinders the 
effectiveness of GBR.88,89  The down-side to advancing a flap would be the soft-tissue changes, 
such as mucogingival junction discrepancies and esthetic problems.  Therefore, the decision to 
achieve primary closure with flap advancement must be weighed against the soft tissue changes 
that follow.87 
 
Alveolar Ridge Preservation and Management of Extractions 
 
 Often times the loss of teeth results in alveolar ridge resorption.  Because of this, the 
preservation of bone volume at the time of extraction is desirable.87  Carlsson et al. (1967) 
showed that when teeth were extracted from the maxillary anterior, the alveolar process 
diminished greatly during the first six months.  Reduction continued at the site at a reduced rate, 
but was still noticeable at the five-year follow-up.90  It is important that clinicians intervene at 
the time of extraction to preserve alveolar bone.  Clinicians must also conservatively manage the 







 Iasella et al. (2003) studied whether ridge preservation would prevent the typical 
horizontal and vertical resorptive changes seen clinically following extraction.  Non-molar teeth 
were extracted and randomly selected to receive ridge preservation using freeze-dried bone 
allograft and a collagen membrane or no material.  The sites were allowed to heal for four to six 
months.  In evaluating horizontal changes, they found that although both groups lost ridge width, 
an improved result was seen in the sites grafted at the time of extraction.  Furthermore, most of 
the resorption took place on the buccal, and maxillary sites lost more width than mandibular 
sites.  In analyzing vertical changes, they found that grafted sites gained vertical height, whereas 
the non-grafted sites lost vertical height.91  
Walker et al. (2017) sought to evaluate alveolar ridge changes following molar extraction 
with and without the use of ridge preservation.  After extraction, sites were either grafted with 
freeze-dried bone allograft covered by a non-resorbable dPTFE membrane or allowed to heal 
naturally.  Cone-beam computed tomography (CBCT) images were taken immediately after 
extraction and three months post-extraction.  They found that there was significantly greater loss 
in alveolar ridge height in the molars that were not grafted at the time of extraction.  They did not 
find a significant difference in ridge width loss between the two groups.  Interesting to note is 
that when ridge preservation was performed, the width diminished evenly between the buccal 
and lingual aspects, whereas when ridge preservation was not performed, the majority of ridge 
width loss occurred on the buccal.92  Considering this finding, placement of future restorations 
could be compromised due to the uneven loss of osseous tissue.   
The evidence overwhelmingly supports that ridge preservation is beneficial in preventing 
dimensional changes that occur soon after dental extractions.  The clinician has an abundant 
variety of materials to choose from in grafting extraction sockets and must take into 







compare in vivo the use of bioengineered Polycaprolactone (Polydopamine Coated and 
Uncoated) scaffolds against a commonly used xenograft, Geistlich Bio-Ossâ, and Control (no 
material) in ridge preservation procedures following first molar extraction in the rat model.  The 
study hypothesis is that Polycaprolactone (Polydopamine Coated and Uncoated) scaffolds will 
perform comparable to Geistlich Bio-Ossâ and show an improvement over the Control (no 















The Institutional Animal Care and Use Committee (IACUC) of Texas A&M University 
College of Dentistry, Dallas, Texas, reviewed and approved the protocol for this in vivo, 
prospective, randomized clinical trial.  A total of 33 male Sprague Dawley rats were used in the 
study between October 2017 and May 2018.   
Rats were weighed and anesthetized with a mixture of ketamine/xylazine 10:1 via 
intraperitoneal injection.  Upon profound anesthesia, the right and left maxillary first molars 
were extracted as atraumatically as possible using curettes and a rongeur.  Using a slow speed 
handpiece, a Brasseler #703 flat-end taper cross-cut fissure 44.5 mm bur was drilled to the depth 
of 3 mm in the extraction sockets to create standardized sized defects.  Rats were randomly 
selected to receive one of four ridge preservation materials to be placed in the right and left 
maxillary first molar extraction sockets: Control (no material), Geistlich Bio-Ossâ (Geistlich 
Pharma AG, Wolhusen, Switzerland), Polycaprolactone (Polydopamine Coated) scaffold (Texas 
A&M University, College Station, TX), or Polycaprolactone (Uncoated) scaffold (Texas A&M 
University, College Station, TX).  Geistlich Bio-Ossâ was hydrated per manufacturer’s 
instructions and the Polycaprolactone discs (Polydopamine Coated and Uncoated) were trimmed 
and prepared for placement.  Enough graft material was placed to completely fill the socket.  A 
Cytoplast RTM Collagen Membrane (Osteogenics Biomedical, Lubbock, TX) was trimmed to 
completely cover the extraction site and placed over the graft material, tucking the membrane 
under the gingiva to prevent dislodgement.  A drop of PeriAcryl (GluStitch Inc., BC, Canada) 







with the exception of having no graft material placed in the extraction sockets.  Following 
recovery, the rats were returned to their quarters and fed a soft diet for three days.  The rats were 
randomly allocated to either be in the four-week experimental group or the eight-week 
experimental group. 
The rats were sacrificed in accordance with guidelines of the National Institute of Health 
(NIH) via CO2 overdose.  The maxillae were dissected, removing all soft tissue remnants.  
Afterwards, the maxillae were hemisected into right and left halves.  The specimens contained 
the surgical site of the maxillary first molar, along with the second and third molars.     
 
Scanning Electron Microscopy (SEM) 
 
 A Polycaprolactone (Polydopamine Coated) disc, a Polycaprolactone (Uncoated) disc, 
and Geistlich Bio-Ossâ particles were sputter coated with Au/Pd alloy (60 seconds for 
Polycaprolactone discs, 120 seconds for Geistlich Bio-Ossâ particles).  The samples were 
analyzed using a scanning electron microscope (JEOL JSM-6010LA) at 17X, 100X, 500X, and 




Right and left hemisected maxillae were fixed in 10% formalin.  Comparative 
radiographs were taken of all samples in a similar sagittal orientation using a Faxitron MX-20 
Specimen Radiography System (Faxitron X-ray Corp., IL) at a standardized distance, at 26 kVp 










 A Micro-CT 20 Scanco Medical Scanner (Zürich, Switzerland) was used to individually 
image eight samples (one sample for each treatment modality per experimental time point).  
Samples were scanned with an x-, y-, and z-axis resolution mode of ~10 µm, a voltage of 55 
kVp, and 800 ms exposure time.  Three-dimensional (3D) reconstructed images were prepared 
using the micro-CT scanner software.  Images were displayed to include both an overall gross 
image of the specimen as well as a cut image to see approximately midway through the surgical 




 Right and left hemisected maxillae were fixed in 10% formalin and decalcified with 10% 
ethylenediaminetetraacetic acid (EDTA) (pH 8) for 5 days using an EMS-820 Precision Pulsed 
Laboratory Microwave Oven (Electron Microscopy Sciences, PA).  The samples were then 
paraffin embedded and sectioned horizontally at 6 µm.  One half of the samples were 
subsequently stained with Hematoxylin and Eosin (H&E) and the other half with Masson’s 
Trichrome using established methods.  Stained sections were analyzed using a Leica DMR light 




 Right and left hemisected maxillae were fixed in 10% formalin and processed for ground 







well as a mixture of alcohol/Technovit 7200 per the EXAKT company protocol in preparation 
for ground sections.  The samples were polymerized and embedded in 100% light cure Technovit 
7200 (Technovit 7200, EXAKT).  A diamond bandsaw (EXACT 300 CP) was used to grossly 
section the samples.  The samples were then polished to produce 20 µm thin sections.  The 
samples were stained with Von Kossa stain and were analyzed using a Leica DMR light 




 Comparative radiographs from three samples were randomly chosen from each treatment 
modality at both time points to measure the bone height in the middle of the extraction, ridge 
preservation site using ImageJ software.  The values were averaged and compared to each other.  
The data analysis was conducted using student’s T-test, and the significance value was set at p < 





















Scanning Electron Microscopy (SEM) 
 
 Geistlich Bio-Ossâ: At 17x magnification, the particles displayed irregular, sharped edge 
shapes.  Porosity was seen in several of the particles examined.  At higher magnifications of 
100x and 500x, interparticle pores could be observed.  See Figure 1. 
Polycaprolactone (Uncoated):  At 17x magnification, a highly porous specimen is 
observed.  At higher magnifications of 100x and 500x, an interconnection network of pores can 
be seen.  At 1000x, there appears to be irregularly arranged microscopic pores on the flat 
surfaces.  See Figure 2. 
Polycaprolactone (Polydopamine Coated): At 17x magnification, a highly porous 
specimen is observed.  At higher magnifications of 100x and 500x, an interconnection of the 
pores can be seen.  At 1000x, the irregularly arranged microscopic pores seen on the flat surfaces 




At 4 weeks, the average bone height in the middle of the extraction socket was: Control 
9.167 mm ± 1.312 mm,  Geistlich Bio-Ossâ 10.667 mm ± 1.247 mm, Polycaprolactone 
(Uncoated) 10.500 mm ± 0.707 mm, and Polycaprolactone (Polydopamine Coated) 10.667 mm ± 
0.624 mm.  The difference in the values of average bone height was not statistically significant 







At 8 weeks, the average bone height in the middle of the extraction socket was: Control 
9.167 mm ± 0.235 mm,  Geistlich Bio-Ossâ 12.667 mm ± 0.849 mm, Polycaprolactone 
(Uncoated) 11.833 mm ± 0.236 mm, and Polycaprolactone (Polydopamine Coated) 11.333 mm ± 
0.471 mm.  The difference in the values of average bone height was statistically significant (p < 
0.05) between Control and Geistlich Bio-Ossâ, between Control and Polycaprolactone 
(Uncoated), and between Control and Polycaprolactone (Polydopamine Coated) at 8 weeks.  The 
difference in the values of average bone height was not statistically significant (p > 0.05) 
between Geistlich Bio-Ossâ and Polycaprolactone (Uncoated) and Polycaprolactone 
(Polydopamine Coated) at 8 weeks, and between Polycaprolactone (Uncoated) and 




 Comparison with gross samples and cut sections reveal that greater bone fill was evident 
with the 8-week samples compared with the 4-week samples.  In the 4-week samples, the 
greatest fill of the extraction socket appears most evident with Polycaprolactone (Polydopamine 
Coated) samples, while the Control, Geistlich Bio-OssÒ, and Polycaprolactone (Uncoated) 
demonstrate comparable results.  There is a loss of ridge height present at the extraction site in 
all 4-week samples.  Bone loss extending to or past the furcation is noted in the remaining 
maxillary 2nd and 3rd molars of all 4-week samples.  In the 8-week samples, it appears that the 
extraction sockets of the Geistlich Bio-OssÒ, Polycaprolactone (Uncoated), and 
Polycaprolactone (Polydopamine Coated) are filling with osseous tissue.  There is a loss of ridge 
height present at the extraction site in all 8-week samples.  Residual ridge height of Geistlich 







extending to or past the furcation is noted in the remaining maxillary 2nd and 3rd molars of all 8-




 H&E: New bone formation was seen in both 4-week and 8-week samples for all materials 
tested.  Under low magnification (2x), more soft tissue was present in the defect sites of the 4-
week samples compared to the 8-week samples.  See Figures 8 and 9.   
In viewing the samples at higher magnification (20x), direct ossification via bone lining 
cells, osteoblasts, and osteocytes was present in the Control, Geistlich Bio-Ossâ, and 
Polycaprolactone (Uncoated) samples at both 4- and 8-weeks.  However, the Polycaprolactone 
(Polydopamine Coated) samples demonstrated evidence of endochondral ossification at both 4- 
and 8-weeks. See Figures 10 and 11.   
 Masson’s Trichrome: New bone formation was evident within the extraction socket 
connective tissue at 8 weeks for all samples viewed at low magnification (5x).  Geistlich Bio-
Ossâ samples demonstrated the most regular appearance of new bone formation.  Both 
Polycaprolactone (Uncoated) and (Polydopamine Coated) samples displayed more new bone 




 Von Kossa staining: In observing the 4-week samples at 10x magnification, no evidence 
of new mineralized tissue inside the fibrous connective tissue of the alveolar socket was 







the fibrous connective tissue and osseous tissue.  See Figure 13.  In observing the 8-week 
samples at 10x magnification, new mineralized tissue formation was seen inside the fibrous 









4. DISCUSSION AND CONCLUSION 
      
Discussion 
 
 In this study, thermoresponsive SMP, Polycaprolactone (Polydopamine Coated and 
Uncoated), were assessed and compared against Geistlich Bio-Ossâ and Control (no material) in 
extraction, ridge preservation procedures in the rat model.  Polycaprolactone is advantageous 
because of its elasticity, biocompatibility, and biodegradability.72  Furthermore, the scaffold can 
be bioengineered by the application of a bioactive polydopamine coating to enhance 
hydrophilicity and HA formation when placed in osseous defects.72       
 Zhang et al. (2014) tested the same Polycaprolactone (Polydopamine Coated and 
Uncoated) scaffolds used in this study and found an advantage to having a bioactive coating in in 
vitro studies.  They found that the Polydopamine Coated scaffolds showed significant HA 
mineralization and enhanced capacity for osteoblast adhesion and proliferation over the 
Uncoated scaffolds.72  Our in vivo study showed that both the Polydopamine Coated and 
Uncoated treated sites had comparable results at both time points.  The scaffolds did differ in that 
the Polydopamine Coated samples showed evidence of endochondral ossification, whereas the 
Uncoated samples showed evidence of direct ossification, which was in alignment with the 
Geistlich Bio-Ossâ and Control samples.   
 In all micro-CT images analyzed, it was noted that there appeared to be loss of vertical 
height at the ridge preservation site.  This finding is consistent with other studies that show 
extraction sites, whether grafted or not grafted, still lose vertical height from the initial baseline 







micro-CT measurements, so it is unknown how much of a vertical loss in hard tissue height 
resulted.   
 The surgeon (TD) used the same microscope during all extraction, ridge preservation 
surgeries to enhance visualization.  To the best of the surgeon’s ability, it was assumed that all 
tooth and root fragments had been extracted.  However, in analyzing a few samples after 
processing, it had been discovered that some samples contained root fragment remnants.  
Glickman et al. (1947) concluded that retained root remnants and bone fragments slow the 
progress of post-extraction healing.  They did find that root remnants deep in the wound are well 
tolerated by the surrounding tissues, whereas remnants close to the surface prevent epithelial 
closure which increased inflammation.37  It is possible that the retained root fragments could 




 In conclusion, both Polycaprolactone (Uncoated) and (Polydopamine Coated) scaffolds 
performed comparably to Geistlich Bio-Ossâ as a ridge preservation material over the Control 
(no material).  Though new bone formation was seen with all treatment modalities, there was an 
improvement seen in using a graft over not using a graft.  Alloplastic scaffolds have the added 
advantage over allografts and xenografts in that they can be bioengineered to promote 
regeneration.  As newer technology develops, they have the potential to perform even better than 
what is currently used.  The use of Polycaprolactone scaffolds was shown to be beneficial in 
ridge preservation procedures, thus warranting the possibility of future investigations of these 
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Figure 8.  H&E (2x), 4 Weeks.  (A) Control, (B) Geistlich Bio-OssÒ, (C) Polycaprolactone 





Figure 9.  H&E (2x), 8 Weeks.  (A) Control, (B) Geistlich Bio-OssÒ, (C) Polycaprolactone 










Figure 10.  H&E (20x), 4 Weeks.  (A) Control, (B) Geistlich Bio-OssÒ, (C) Polycaprolactone 










Figure 11.  H&E (20x), 8 Weeks.  (A) Control, (B) Geistlich Bio-OssÒ, (C) Polycaprolactone 










Figure 12.  Masson’s Trichrome (5x), 8 Weeks.  (A) Control, (B) Geistlich Bio-OssÒ, (C) 




















Figure 14.  Von Kossa Stain (10x), 8 Weeks.  (A) Control, (B) Geistlich Bio-OssÒ, (C) 




















Table 2.  8 weeks in vivo results. 
 
 
 
 
 
 
